Outlook Therapeutics Inc (OTLK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2019 | 09-2018 | 09-2017 | 09-2016 | 09-2015 | |
| Sales | 8,146 | 3,088 | 3,812 | 2,980 | 5,219 |
| Gross Profit | 8,146 | 3,088 | 3,812 | 2,980 | 5,219 |
| Operating Expenses | 44,445 | 32,732 | 39,692 | 54,327 | 51,782 |
| Operating Income | -36,299 | -29,644 | -35,880 | -51,347 | -46,563 |
| Interest Expense | 3,467 | 3,891 | 5,626 | 1,852 | 2,297 |
| Other Income | 1,831 | -205 | 3,159 | 0 | 0 |
| Pre-tax Income | -37,935 | -33,740 | -38,348 | -53,199 | -48,860 |
| Income Tax | -3,411 | -3,648 | 502 | 103 | -190 |
| Net Income Continuous | -34,524 | -30,092 | -38,849 | -53,302 | -48,670 |
| Minority Interests | N/A | N/A | N/A | N/A | -1,277 |
| Net Income | $-34,524 | $-30,092 | $-38,849 | $-53,302 | $-47,393 |
| EPS Basic Total Ops | -39.60 | -194.80 | -267.20 | -587.20 | -868.80 |
| EPS Basic Continuous Ops | -37.95 | -122.03 | -258.76 | -495.46 | -798.36 |
| EPS Diluted Total Ops | -39.60 | -194.80 | -288.00 | -587.20 | -868.80 |
| EPS Diluted Continuous Ops | -37.95 | -122.03 | -258.54 | -495.46 | -798.36 |
| EPS Diluted Before Non-Recurring Items | -39.60 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-32,937 | $-26,590 | $-33,188 | $-48,953 | $-44,738 |